Publication | Closed Access

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

Breast OncologyMedicineGynecologyBreast CancerBreast CarcinomaCancer TreatmentOncologyCell BiologyHigh-dose MelphalanOvarian CancerPhase I–ii Study